Identification of a binding domain of the endothelin-B receptor using a selective IRL-1620-derived photoprobe.

No abstract is available for this paper.

• Publication year

  2004

• Venue

  Biochemistry

• Publication date

  2004-09-14

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1021/BI049246XPMID 15350137
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Structural studies on endothelin receptor subtype B specific agonist IRL 1620 [suc-[Glu9, Ala11,15]ET-1(8-21)] and its analogs with dipalmitoyl phosphatidylcholine vesicles by NMR spectroscopy.

  2009cited by this paper
• Structural basis of the function of endothelin receptor

  2004cited by this paper
• Photolabelling the rat urotensin II/GPR14 receptor identifies a ligand-binding site in the fourth transmembrane domain.

  2003cited by this paper
• Role of endothelin in human hypertension.

  2003cited by this paper
• Residues 293 and 294 are ligand contact points of the human angiotensin type 1 receptor.

  2002cited by this paper
• Development and validation of opioid ligand-receptor interaction models: the structural basis of mu vs delta selectivity.

  2002cited by this paper
• The Extracellular N Terminus of the Endothelin B (ETB) Receptor Is Cleaved by a Metalloprotease in an Agonist-dependent Process*

  2002cited by this paper
• Evidence for Spatial Proximity of Two Distinct Receptor Regions in the Substance P (SP)·Neurokinin-1 Receptor (NK-1R) Complex Obtained by Photolabeling the NK-1R withp-Benzoylphenylalanine3-SP*

  2001cited by this paper
• Endothelin in renal diseases and cardiovascular remodeling in renal failure.

  2001cited by this paper
• Potential role of endothelin-1 and endothelin antagonists in cardiovascular diseases

  2000cited by this paper
• Ligand binding sites on guinea pig C3aR: point and deletion mutations in the large extracellular loop and vicinity.

  1999cited by this paper
• A structure-activity study of a C-terminal endothelin analogue.

  1998cited by this paper
• Structure-activity analysis of C-terminal endothelin analogues.

  1998cited by this paper
• Identification and characterization of a novel endothelin receptor that binds both ETA- and ETB-selective ligands.

  1997cited by this paper
• Dissociation characteristics of endothelin receptor agonists and antagonists in cloned human type-B endothelin receptor.

  1997cited by this paper
• Biological and molecular analyses of structurally reduced analogues of endothelin-1.

  1996cited by this paper
• Ligand binding domain of the human endothelin-B subtype receptor.

  1995cited by this paper
• Aspartate mutation distinguishes ETA but not ETB receptor subtype‐selective ligand binding while abolishing phospholipase C activation in both receptors

  1995cited by this paper
• Separable binding sites for the natural agonist endothelin-1 and the non-peptide antagonist bosentan on human endothelin-A receptors.

  1995cited by this paper
• Species differences in the binding characteristics of [125I]IRL-1620, a potent agonist specific for endothelin-B receptors.

  1994cited by this paper
• His145-Trp146 residues and the disulfide-linked loops in atrial natriuretic peptide receptor are critical for the ligand-binding activity.

  1994cited by this paper
• International Union of Pharmacology nomenclature of endothelin receptors.

  1994cited by this paper
• Identification of specific regions of the human endothelin-B receptor required for high affinity binding with endothelin-3.

  1994cited by this paper
• Human endothelin receptor ETB. Amino acid sequence requirements for super stable complex formation with its ligand.

  1994cited by this paper
• Alanine scan of endothelin: importance of aromatic residues.

  1994cited by this paper
• Distinct subdomains of human endothelin receptors determine their selectivity to endothelinA-selective antagonist and endothelinB-selective agonists.

  1993cited by this paper
• Functionally distinct endothelin B receptors in vascular endothelium and smooth muscle.

  1993cited by this paper
• Contractile responses and signal transduction of endothelin-1 in aorta and mesenteric vasculature of adult spontaneously hypertensive rats.

  1993cited by this paper
• A reversible radioligand specific for the ETB receptor: [125I]Tyr13-Suc-[Glu9,Ala11,15]-endothelin-1(8- 21), [125I]IRL 1620.

  1992cited by this paper
• Pharmacological and histological examinations of regional differences of guinea‐pig lung: a role of pleural surface smooth muscle in lung strip contraction

  1992cited by this paper
• A potent and specific agonist, Suc-[Glu9,Ala11,15]-endothelin-1(8-21), IRL 1620, for the ETB receptor.

  1992cited by this paper
• Replacement of lysine‐181 by aspartic acid in the third transmembrane region of endothelin type B receptor reduces its affinity to endothelin peptides and sarafotoxin 6c without affecting G protein coupling

  1992cited by this paper
• Modulation by endothelium of the responses induced by endothelin‐1 and by some of its analogues in rat isolated aorta

  1991cited by this paper
• [Ala1,3,11,15]endothelin-1 analogs with ETB agonistic activity.

  1991cited by this paper
• Affinity labelling of endothelin receptor and characterization of solubilized endothelin-endothelin-receptor complex.

  1990cited by this paper
• Identification of endothelin receptors by chemical cross-linking.

  1990cited by this paper
• The human endothelin family: three structurally and pharmacologically distinct isopeptides predicted by three separate genes.

  1989cited by this paper
• A novel potent vasoconstrictor peptide produced by vascular endothelial cells

  1988cited by this paper
• p-Benzoyl-L-phenylalanine, a new photoreactive amino acid. Photolabeling of calmodulin with a synthetic calmodulin-binding peptide.

  1986cited by this paper
• Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4

  1970cited by this paper

• Electroporation-Aided DNA Immunization Generates Polyclonal Antibodies Against the Native Conformation of Human Endothelin B Receptor

  2011influential citation
• New perspectives on the endothelin axis in pain.

  2011cites this paper
• Structural determinants for selective recognition of peptide ligands for endothelin receptor subtypes ETA and ETB

  2009cites this paper
• Endothelin receptors and pain.

  2009cites this paper
• Identification of ETA and ETB binding domains using ET-derived photoprobes.

  2008cites this paper
• Functional analysis of cell‐free‐produced human endothelin B receptor reveals transmembrane segment 1 as an essential area for ET‐1 binding and homodimer formation

  2007cites this paper
• Transmembrane domain V of the endothelin-A receptor is a binding domain of ETA-selective TTA-386-derived photoprobes.

  2005cites this paper